Loading
  • Babraham Hall CambridgeCardiff Medicentre Cardiff
  • Call us on +44 (0) 1223 804075

Nemesis Bioscience today announced the appointment of Dr Mark McCamish as Scientific Advisor for the development of its suite of Bacterial Cybergenetics© technologies. These include Nemesis Symbiotics© for applications including the reversal of antibiotic resistance and Transmids© for their clinical, veterinary and industrial delivery. Mark, an investor in Nemesis, is currently President and CEO of Forty